New Brain Tumor Test Replaces Risky Surgery for 10 Patients

Ten people with brain tumors just got their diagnosis without anyone cutting into their skulls. Instead, doctors at Niigata University in Japan used a simple spinal tap to detect cancer DNA floating in their cerebrospinal fluid.

The patients all had primary central nervous system lymphoma, a cancer that develops deep in the brain. Their tumors sat in or near the brainstem, one of the most delicate and dangerous areas to operate on.

Traditional diagnosis requires surgeons to cut through brain tissue to collect a sample. For these 10 patients, that wasn't an option. Some had tumors in spots too risky to reach. Others were too sick to survive the operation.

Dr. Manabu Natsumeda and his team tried something different. They collected spinal fluid through a lumbar tap, the same procedure used for epidurals. Then they searched that fluid for a specific mutation called MYD88 L265P, which appears in this type of lymphoma.

The test worked perfectly. All 10 patients showed the mutation. Doctors started treatment immediately based on those results alone, skipping brain surgery entirely.

The method, called liquid biopsy, has been gaining ground in cancer diagnosis. But using it as the sole basis for starting brain tumor treatment marks new territory. Dr. Natsumeda calls it "a potential game changer" for patients who can't safely undergo traditional biopsies.

The Ripple Effect

This success could reshape how doctors approach difficult brain tumors. Right now, surgical biopsy remains the gold standard, meaning patients with unreachable tumors often face impossible choices between risky surgery and no diagnosis at all.

The Japanese team's results, published in Neuro-Oncology Advances, show liquid biopsy can be reliable enough to guide treatment decisions. That reliability matters because starting cancer treatment without confirming the diagnosis first has always been considered too dangerous.

The technique particularly helps elderly patients or those with other health problems that make surgery life-threatening. It also speeds up the path to treatment, eliminating weeks of recovery time from brain surgery before chemotherapy can begin.

Other research teams have been exploring liquid biopsy for various brain tumors, but this study stands out for actually treating patients based solely on these results. The team's confidence came from the test's perfect accuracy in detecting that specific mutation.

Doctors still need larger studies to confirm the approach works broadly and safely, but these 10 successful cases open the door to less invasive cancer care where it matters most.